The Presidential Symposium "Eyes to the future" will feature the first-ever presentation of the clinical trial portion of the PIONeeR...

Enrollment in the biomarker study is now completed (see news from January 5, 2023) but remains open in the PIONeeR Project’s umbrella...

The RHU PIONeeR Project announces the completion of a major milestone with more than 450 patients enrolled in the biomarker part of the...

Le projet PIONeeR explore plus de 400 paramètres différents chez des patients atteints de cancers bronchiques avancés, traités par des...

One of the key steps in the PIOneeR protocol is biopsy processing by histopathology, which is performed at the pathology service led by...

Following the third Scientific Advisory Board Meeting, which took place virtually on March 12th, 2021, and after seeing the project’s...

A collection of brief summaries covering recent advances in immuno-oncology that we deem important from the perspective of The PIONeeR...

Projet international de recherche PIONeeR : mieux comprendre, prévenir et contourner les résistances à l’immunothérapie dans le cancer du...

The Pioneer Project is the first study to assess over 400 biomarkers for predictive value in advanced non-small cell lung cancers (NSCLC)...

Fruit of the collaboration between the National Institute for Research in Digital Science and Technology (INRIA) and the PIONeeR...

An original format of conference series: Time 1: world-class specialists and MI scientists discuss new research and innovation...